AHF issued the next statement in response to the WHO’s announcement to pull three Ranbaxy Laboratories’ drugs off of their approved medications list in the developing world. At the same time when the Bush administration is usually forbidding the usage of generic drugs in the developing world – – depriving millions access to life-saving drugs – – it really is great to see that the World Health Organization is shopping for the interests of poor people coping with HIV and AIDS, said Michael Weinstein, President of Helps Healthcare Foundation. It really is very clear from the WHO’s latest announcement that they have in place an established system that closely monitors the safety and efficacy of generic ARVs. The phony fig leaf of claiming that generics are unsafe is merely a way to perform the bidding of big pharma.The chance of cardiovascular system disease events was decreased by 14 percent and the chance of fresh or worsening kidney disease was decreased by 21 percent. But concerted actions is urgently necessary to ensure that sufferers with diabetes are determined and given treatments which can improve essential outcomes like survival. Notes: The Progress Research was conducted by a global group of independent medical scientists with support from Servier, the maker of indapamide and perindopril, and the National Medical and Health Research Council of Australia. Perindopril can be an angiotensin transforming enzyme inhibitor and indapamide is definitely a thiazide-like diuretic.